Search results
- Most recently, on Thursday, December 28th, Randal J. Kirk bought 96,686 shares of Precigen stock. The stock was acquired at an average cost of $1.41 per share, with a total value of $136,327.26. Following the completion of the transaction, the director now directly owns 1,096,686 shares of the company's stock, valued at $1,546,327.26.
www.insidertrades.com › precigen-inc-stock › randal-j-kirk
Feb 1, 2023 · The Trade: Precigen, Inc. (NASDAQ:PGEN) Director Randal J Kirk bought a total of 11,428,571 shares at an average price of $1.75. To acquire these shares, it cost around $20 million . What’s...
- Lisa Levin
Detailed Profile of KIRK RANDAL J portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more.
Dec 28, 2023 · The estimated net worth of Randal J. Kirk is at least $1.58 million as of December 28th, 2023. Mr. Kirk owns 1,096,686 shares of Precigen stock worth more than $1,579,228 as of May 7th.
- (301) 556-9900
- Director, Precigen
- investors@precigen.com
The estimated net worth of Randal J Kirk is at least $982 Million dollars as of 2024-05-02. Randal J Kirk is the 10% Owner of Halozyme Therapeutics Inc and owns about 14,092,771 shares of Halozyme Therapeutics Inc (HALO) stock worth over $562 Million.
May 3, 2024 · KIRK RANDAL J Total Shares: 93.3m. Subject Company: Precigen Inc. (Intrexon) View Complete Ownership History. Backtest Filed as of Date: 2024-05-03: Event Date: 2024 ...
May 4, 2024 · The estimated Net Worth of Randal J Kirk is at least $134 Million dollars as of 9 March 2024. Mr. Mr. Kirk owns over 213,675 units of Precigen Inc stock worth over $43,589,987 and over the last 17 years he sold PGEN stock worth over $88,624,666.
Jun 18, 2019 · Chief Executive Officer Randal J. Kirk acquired 805,447 shares of this biotech company, paying $5.24 per share for a total amount of $4.22 million.
